"Since its founding AOCC is dedicated to the diagnosis and treatment of persons with arthritis, osteoporosis and related connective tissue diseases and providing comprehensive, innovative and compassionate care to our patients."

During the past decade, Arthritis and Osteoporosis Consultants of the Carolinas conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis and Osteoporosis Consultants of the Carolinas" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Osteoporosis Consultants of the Carolinas" #1 collaborator was "Hexal AG" with 1 trials as a collaborator, "Napp Pharmaceuticals Limited" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis and Osteoporosis Consultants of the Carolinas" are "Rheumatoid Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Chronic Non-malignant Pain" (1 trials), "Chronic Nonmalignant Pain" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Arthritis and Osteoporosis Consultants of the Carolinas" in a lesser frequency.

Most popular intervention types in "Arthritis and Osteoporosis Consultants of the Carolinas" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine transdermal patch" (2 trials), "Placebo" (2 trials), "Baricitinib" (1 trials), "GP2013 - A Proposed biosimilar rituximab" (1 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis and Osteoporosis Consultants of the Carolinas" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis and Osteoporosis Consultants of the Carolinas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Arthritis and Osteoporosis Consultants of the Carolinas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis and Osteoporosis Consultants of the Carolinas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".